Home » Newsletters » BioWorld Science

BioWorld Science

May 31, 2010

View Archived Issues

Preclinical studies support investigation of CEM-101 in COPD

TEI-3252 identified as bifunctional bronchodilator

LX-1031 alleviates disease symptoms in phase II trial in IBS

UFD1L gene SNP correlates with early-onset schizophrenia

Favorable data presented on riociguat in pulmonary hypertension

AM-206 improves symptoms of allergic rhinitis in vivo

Tranexamic acid tablets reduce menstrual blood loss in clinical trials

Galderma claims new melanocortin MC4 receptor antagonists

NeuroSearch claims new K(V)7 potassium channel activators

Organon claims new HCN channel-modulating analgesics

Shanghai Genomics claims new protein kinase inhibitors

Funxional Therapeutics raises funds for phase II FX-125L trials in inflammation

AstraZeneca reports developments for first quarter 2010

NICE issues recommendation for somatropin products, including Omnitrope

New phase II data disclosed on simplified Visonac procedure

CrystalGenomics merges with BexPharm

Advanced Life Sciences expands Restanza collaboration with U.S. government

Pfizer halts Inspra trial early after significant benefit is shown

Bionomics provides overview of clinical programs

Prolia obtains marketing authorization in E.U.

Vertex identifies new ABC transporter modulators

FDA committee recommends approval of tesamorelin

NewLink begins phase III HyperAcute-Pancreas immunotherapy trial

CSL Behring gains national marketing authorizations for Berinert

Two phase III Heplisav trials cleared to continue immunizations

FDA and EMA approve reanalysis of images from phase III RG-1068 trial

Short-acting anesthetic/sedative CNS-7056 enters phase IIb trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...